News

BioSpace2h

Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues

CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
Infectious Disease Advisor3h

Vinay Prasad Returns to FDA After Being Ousted

The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.
MedPage Today5h

Soap Recall Over Sepsis Risk; FDA Rehires Vinay Prasad; NIH Reports Patient to ICE

DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...
The BMJ7h

Vinay Prasad reinstated to FDA vaccines role, 14 days after resignation

Vinay Prasad was reinstated as the head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug ...
Northwest Asian Weekly21h

Ousted FDA vaccine chief Vinay Prasad is returning to the agency

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...
JD Supra22h

The Return of CBER Director Prasad, FDA Announces New Chief Counsel, and FDA Budget Watch

In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...

Study: AI programs might help ER overcrowding in hospitals

Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...
STAT23h

Prasad returns to the FDA, Attack on the CDC

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...